Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Bianco

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|March 1, 2021
Defining the disease course of TNFα blockers-associated Multiple SclerosisMatteo Lucchini, Guido Maria Giuffrè, Viviana Nociti, et al.
Journal of Neuro-Oncology|February 14, 2009
Glioblastoma in multiple sclerosis: a case reportGiovanni Frisullo, Agata Katia Patanella, Viviana Nociti, et al.
Multiple Sclerosis and Related Disorders|November 8, 2025
IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort studyAssunta Bianco, Arianna Aruanno, Matteo Lucchini, et al.
Journal of Neuroimmunology|October 26, 2013
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosisDomenico Plantone, Alessandro Marti, Giovanni Frisullo, et al.
Journal of Personalized Medicine|April 23, 2022
The Expanding Role of the Infectious Disease Expert in the Context of the MS CentreMatteo Lucchini, Paola Del Giacomo, Valeria De Arcangelis, et al.
Molecular Neurobiology|October 10, 2022
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisMatteo Lucchini, Valeria De Arcangelis, Geny Piro, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2007
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patientsGiovanni Frisullo, Viviana Nociti, Raffaele Iorio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2022
A true isolated cognitive relapse in multiple sclerosisValeria Pozzilli, Alessandro Cruciani, Fioravante Capone, et al.
European Neurology|November 18, 2014
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumabAssunta Bianco, Agata Katia Patanella, Viviana Nociti, et al.
Multiple Sclerosis and Related Disorders|November 2, 2019
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patientsAssunta Bianco, Pier-Valerio Mari, Anna Rita Larici, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|March 1, 2021
Defining the disease course of TNFα blockers-associated Multiple SclerosisMatteo Lucchini, Guido Maria Giuffrè, Viviana Nociti, et al.
Journal of Neuro-Oncology|February 14, 2009
Glioblastoma in multiple sclerosis: a case reportGiovanni Frisullo, Agata Katia Patanella, Viviana Nociti, et al.
Multiple Sclerosis and Related Disorders|November 8, 2025
IgE-mediated allergic reactions to ocrelizumab in multiple sclerosis: A retrospective cohort studyAssunta Bianco, Arianna Aruanno, Matteo Lucchini, et al.
Journal of Neuroimmunology|October 26, 2013
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosisDomenico Plantone, Alessandro Marti, Giovanni Frisullo, et al.
Journal of Personalized Medicine|April 23, 2022
The Expanding Role of the Infectious Disease Expert in the Context of the MS CentreMatteo Lucchini, Paola Del Giacomo, Valeria De Arcangelis, et al.
Molecular Neurobiology|October 10, 2022
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisMatteo Lucchini, Valeria De Arcangelis, Geny Piro, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2007
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patientsGiovanni Frisullo, Viviana Nociti, Raffaele Iorio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 7, 2022
A true isolated cognitive relapse in multiple sclerosisValeria Pozzilli, Alessandro Cruciani, Fioravante Capone, et al.
European Neurology|November 18, 2014
Second-line therapy with fingolimod for relapsing-remitting multiple sclerosis in clinical practice: the effect of previous exposure to natalizumabAssunta Bianco, Agata Katia Patanella, Viviana Nociti, et al.
Multiple Sclerosis and Related Disorders|November 2, 2019
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patientsAssunta Bianco, Pier-Valerio Mari, Anna Rita Larici, et al.
Pageof 4